Serveur d'exploration H2N2 - Curation (Ncbi)

Index « Keywords » - entrée « Cross Reactions »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cross Protection (immunology) < Cross Reactions < Cross Reactions (genetics)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 34.
[0-20] [0 - 20][0 - 34][20-33][20-40]
Ident.Authors (with country if any)Title
000018 (2000) H. Masaki [Japon] ; M. Tamura ; I. KuraneInduction of cytotoxic T lymphocytes of heterogeneous specificities by immunization with a single peptide derived from influenza A virus.
000142 (2006) Edwin D. KilbourneInfluenza immunity: new insights from old studies.
000143 (2006) Suzanne L. Epstein [États-Unis]Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.
000192 (2006) J A Desheva [Russie] ; X H Lu ; A R Rekstin ; L G Rudenko ; D E Swayne ; N J Cox ; J M Katz ; A I KlimovCharacterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
000240 (????) Iu A. Desheva ; Kh Lu ; A R Rekstin ; D M Kats ; L G Rudenko ; A I Klimov[The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].
000263 (2008) Michelle Roti [États-Unis] ; Junbao Yang ; Deanna Berger ; Laurie Huston ; Eddie A. James ; William W. KwokHealthy human subjects have CD4+ T cells directed against H5N1 influenza virus.
000352 (2009) Reiko Yoshida [Japon] ; Manabu Igarashi ; Hiroichi Ozaki ; Noriko Kishida ; Daisuke Tomabechi ; Hiroshi Kida ; Kimihito Ito ; Ayato TakadaCross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
000367 (2008) Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton KatlinskySafety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
000533 (2010) Grace L. Chen ; Elaine W. Lamirande ; Chin-Fen Yang ; Hong Jin ; George Kemble ; Kanta SubbaraoEvaluation of Replication and Cross-Reactive Antibody Responses of H2 Subtype Influenza Viruses in Mice and Ferrets▿
000682 (2011) Nobuko Ohshima ; Yoshitaka Iba ; Ritsuko Kubota-Koketsu [Japon] ; Yoshizo Asano [Japon] ; Yoshinobu Okuno [Japon] ; Yoshikazu KurosawaNaturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5 ▿§
000777 (2012) Jenny Aurielle B. Babon [États-Unis] ; John Cruz [États-Unis] ; Francis A. Ennis [États-Unis] ; Liusong Yin [États-Unis] ; Masanori Terajima [États-Unis]A Human CD4+ T Cell Epitope in the Influenza Hemagglutinin Is Cross-Reactive to Influenza A Virus Subtypes and to Influenza B Virus
000818 (1990) I N Mbawuike [États-Unis] ; H R Six ; T R Cate ; R B CouchVaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.
000891 (2013) Cyrille Dreyfus ; Damian C. Ekiert ; Ian A. WilsonStructure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin
000B02 (2015) Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie]A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets.
000B57 (2015) Yulia A. Desheva [Russie] ; Tatiana A. Smolonogina [Russie] ; Svetlana A. Donina [Russie] ; Larisa G. Rudenko [Russie]Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
000B66 (2015) Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Victor V. Kuprianov [Russie] ; Elena A. Blokhina [Russie] ; Marina V. Potapchuk [Russie] ; Alexander V. Korotkov [Russie] ; Andrey N. Gorshkov [Russie] ; Marina A. Kasyanenko [Russie] ; Nikolai V. Ravin [Russie] ; Oleg I. Kiselev [Russie]Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
000C51 (2015) Ankita Malik [Inde] ; V Vamsee Aditya Mallajosyula [Inde] ; Nripendra Nath Mishra [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde]Generation and Characterization of Monoclonal Antibodies Specific to Avian Influenza H5N1 Hemagglutinin Protein.
000D49 (2017) Zhu-Nan Li [États-Unis] ; Jessica F. Trost [États-Unis] ; Kimberly M. Weber [États-Unis] ; Elizabeth H. Lemasters [États-Unis] ; Sharifa Nasreen [Bangladesh] ; Javan Esfandiari [États-Unis] ; Angelo H. Gunasekera [États-Unis] ; Megan Mccausland [États-Unis] ; Katharine Sturm-Ramirez [États-Unis] ; Jens Wrammert [États-Unis] ; Sean Gregory [États-Unis] ; Vic Veguilla [États-Unis] ; James Stevens [États-Unis] ; Joseph D. Miller [États-Unis] ; Jacqueline M. Katz [États-Unis] ; Min Z. Levine [États-Unis]Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.
000D75 (1988) A. Müllbacher ; G L Ada ; R T HlaGamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A viruses.
000D93 (2017) Dennis E. Te Beest [Pays-Bas] ; Erwin De Bruin [Pays-Bas] ; Sandra Imholz [Pays-Bas] ; Marion Koopmans [Pays-Bas] ; Michiel Van Boven [Pays-Bas]Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2)
000E22 (2017) Troy C. Sutton [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Kevin W. Bock [États-Unis] ; Ian N. Moore [États-Unis] ; Wouter Koudstaal [Pays-Bas] ; Muniza Rehman [Pays-Bas] ; Gerrit Jan Weverling [Pays-Bas] ; Jaap Goudsmit [Pays-Bas] ; Kanta Subbarao [États-Unis]In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Cross Reactions" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Cross Reactions" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Cross Reactions
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021